SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001172661-19-000927
Filing Date
2019-03-11
Accepted
2019-03-11 16:06:23
Documents
1
Group Members
ROBERTO MIGNONE

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G HOLDINGS REPORT bridger-tgtx030119.htm SC 13G 71914
  Complete submission text file 0001172661-19-000927.txt   73821
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51051 | Film No.: 19672339
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016
Business Address 90 PARK AVENUE, 40TH FLOOR NEW YORK NY 10016 212-918-0820
BRIDGER MANAGEMENT, LLC (Filed by) CIK: 0001166309 (see all company filings)

IRS No.: 582553507 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G